1 Min Read
* Morgan Stanley reports 5.2 percent passive stake in Novelion Therapeutics Inc as of Sept 12, 2017 - SEC filing Source text: (bit.ly/2xoCYt9) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.